FDA May Require Cancer-Risk Labeling on Johnson & Johnson Drug
WASHINGTON (AP) — An experimental drug from a unit of Johnson & Johnson appears effective at treating a severe skin disease, though government regulators said Friday it also could slightly increase cancer risks.